An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes

Diabetologia

Volumn 54, Issue 12, 2011, Pages 3062-3070

  Mehers, K L ^a   Long, A E ^a   Van Der Slik, A R ^b   Aitken, R J ^a   Nathwani, V ^a   Wong, F S ^c   Bain, S ^d   Gill, G ^e   Roep, B O ^b   Bingley, P J ^a   Gillespie, K M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d SWANSEA UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Human leucocyte antigen; Killer immunoglobulin like receptor; Natural killer cell; Type 1 diabetes

Indexed keywords

LIGAND;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE ACTIVATION; GENE CONTROL; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC DISORDER; GENOTYPE; HLA C GENE; HOMOZYGOTE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KILLER IMMUNOGLOBULIN LIKE RECEPTOR GENE; KIR2DL2 GENE; KIR2DL3 GENE; KIR2DS2 GENE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; NATURAL KILLER CELL; ONSET AGE; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; INFANT; KILLER CELLS, NATURAL; MALE; RECEPTORS, NATURAL KILLER CELL;

EID: 82455212287     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2299-x     Document Type: Article

References (37)

1. KC Herold A Huen L Gould H Traisman AH Rubenstein 1984 Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena Diabetologia 27 Suppl 102 105 6237011 10.1007/BF00275660 (Pubitemid 14096723)
2. MP Nair EW Lewis SA Schwartz 1986 Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities J Clin Immunol 6 363 372 2429979 10.1007/BF00915375 1:STN:280:DyaL2s%2FjsVWltg%3D%3D (Pubitemid 17195809)
3. K Negishi N Waldeck G Chandy, et al. 1986 Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes Diabetologia 29 352 357 3527835 10.1007/BF00903343 1:STN:280:DyaL28zgtFGqsQ%3D%3D (Pubitemid 16060892)
4. RG Wilson J Anderson BK Shenton MD White RM Taylor G Proud 1986 Natural killer cells in insulin dependent diabetes mellitus Br Med J (Clin Res Ed) 293 244 10.1136/bmj.293.6541.244 1:STN:280:DyaL283ntV2lsQ%3D%3D (Pubitemid 16064229)
5. MJ Hussain L Alviggi BA Millward RD Leslie DA Pyke D Vergani 1987 Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined Diabetologia 30 907 911 3436487 10.1007/BF00295872 1:STN:280:DyaL1c7jslymsw%3D%3D (Pubitemid 18055846)
6. R Lorini A Moretta A Valtorta, et al. 1994 Cytotoxic activity in children with insulin-dependent diabetes mellitus Diabetes Res Clin Pract 23 37 42 7516851 10.1016/0168-8227(94)90125-2 1:STN:280:DyaK2c3otlWjsw%3D%3D (Pubitemid 24118513)
7. HG Ljunggren K Karre 1990 In search of the 'missing self': MHC molecules and NK cell recognition Immunol Today 11 237 244 2201309 10.1016/0167-5699(90) 90097-S 1:CAS:528:DyaK3cXls12rsbc%3D (Pubitemid 20198988)
8. LL Lanier 1998 NK cell receptors Annu Rev Immunol 16 359 393 9597134 10.1146/annurev.immunol.16.1.359 1:CAS:528:DyaK1cXislynt7s%3D (Pubitemid 28183369)
9. Carrington M, Norman P (2003) The KIR gene cluster. NCBI. Available at www.ncbi.nlm.nih.gov/books/NBK10135/
10. M Uhrberg NM Valiante BP Shum, et al. 1997 Human diversity in killer cell inhibitory receptor genes Immunity 7 753 763 9430221 10.1016/S1074-7613(00) 80394-5 1:CAS:528:DyaK1cXjsFShsw%3D%3D (Pubitemid 28064889)
11. C Vilches P Parham 2002 KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 217 251 11861603 10.1146/annurev.immunol.20.092501.134942 1:CAS:528:DC%2BD38XjtlWgt7c%3D (Pubitemid 34293425)
12. MP Martin G Nelson JH Lee, et al. 2002 Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles J Immunol 169 2818 2822 12218090 1:CAS:528:DC%2BD38XntFahtrg%3D (Pubitemid 35013118)
13. JH Yen CH Lin WC Tsai, et al. 2006 Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis Scand J Rheumatol 35 124 127 16641046 10.1080/03009740500381252 1:CAS:528:DC%2BD28XlsFSqsLY%3D
14. DC Jones RS Edgar T Ahmad, et al. 2006 Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility Genes Immun 7 576 582 16929347 10.1038/sj.gene.6364333 1:CAS:528:DC%2BD28XhtFWns7nK (Pubitemid 44614872)
15. JR Hov A Lleo C Selmi, et al. 2010 Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C J Hepatol 52 712 717 20347497 10.1016/j.jhep.2009.11.029 1:CAS:528:DC%2BC3cXlsFKksrg%3D
16. AR van der Slik BP Koeleman W Verduijn GJ Bruining BO Roep MJ Giphart 2003 KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects Diabetes 52 2639 2642 14514651 10.2337/diabetes.52.10.2639 (Pubitemid 37210556)
17. A Shastry SK Sedimbi R Rajalingam, et al. 2008 Combination of KIR 2DL2 and HLA-C1 (Asn) confers susceptibility to type 1 diabetes in Latvians Int J Immunogenet 35 439 446 19046302 10.1111/j.1744-313X.2008.00804.x 1:CAS:528:DC%2BD1cXhsVKitLjP
18. E Ramos-Lopez F Scholten F Aminkeng, et al. 2009 Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding Tissue Antigens 73 599 603 19392800 10.1111/j.1399-0039.2009.01252.x 1:CAS:528:DC%2BD1MXmvVWisb0%3D
19. D Middleton I Halfpenny A Meenagh F Williams J Sivula E Tuomilehto-Wolf 2006 Investigation of KIR gene frequencies in type 1 diabetes mellitus Hum Immunol 67 986 990 17174747 10.1016/j.humimm.2006.08.295 1:CAS:528: DC%2BD28XhtlaktL3L (Pubitemid 44894638)
20. I Santin GP de Nanclares B Calvo A Gaafar L Castano JR Bilbao 2006 Killer cell immunoglobulin-like receptor (KIR) genes in the Basque population: association study of KIR gene contents with type 1 diabetes mellitus Hum Immunol 67 118 124 16698433 10.1016/j.humimm.2006.02.036 1:CAS:528:DC%2BD28Xks1elsbc%3D (Pubitemid 43673913)
21. S Nejentsev JM Howson NM Walker, et al. 2007 Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A Nature 450 887 892 18004301 10.1038/nature06406 1:CAS:528:DC%2BD2sXhtl2nsrjF (Pubitemid 350231332)
22. KM Gillespie SC Bain AH Barnett, et al. 2004 The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes Lancet 364 1699 1700 15530631 10.1016/S0140-6736(04)17357-1 (Pubitemid 39458146)
23. R Hermann M Knip R Veijola, et al. 2003 Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 46 420 425 12687342 1:STN:280:DC%2BD3s7mvVKmug%3D%3D (Pubitemid 36547599)
24. PJ Bingley EA Gale 1989 Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6 BMJ 298 558 560 2495112 10.1136/bmj.298.6673.558 1:STN:280:DyaL1M7psVGhtQ%3D%3D (Pubitemid 19072095)
25. JL Botha H Parker NT Raymond PG Swift 1992 Diabetes diagnosed before the age of 2 years: mortality in a British cohort 8-17 years after onset Int J Epidemiol 21 1132 1137 1483818 10.1093/ije/21.6.1132 1:STN:280: DyaK3s7jtFCntg%3D%3D (Pubitemid 23028592)
26. World Health Organization (1985) Diabetes mellitus: report of a World Health Organization Study Group. World Health Organization, Geneva
27. SC Bain GV Gill PH Dyer, et al. 2003 Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort) Diabet Med 20 808 811 14510860 10.1046/j.1464-5491.2003.01029.x 1:STN:280:DC%2BD3svkvF2jtA%3D%3D (Pubitemid 41701500)
28. J Golding M Pembrey R Jones 2001 ALSPAC-the Avon Longitudinal Study of Parents and Children I. Study methodology. Paediatr Perinat Epidemiol 15 74 87 10.1046/j.1365-3016.2001.00325.x 1:STN:280:DC%2BD3M3jtl2ktg%3D%3D (Pubitemid 32155760)
29. SE Hiby JJ Walker KM O'Shaughnessy, et al. 2004 Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success J Exp Med 200 957 965 15477349 10.1084/jem.20041214 1:CAS:528: DC%2BD2cXovVensL0%3D (Pubitemid 39431121)
30. AR van der Slik BZ Alizadeh BP Koeleman BO Roep MJ Giphart 2007 Modelling KIR-HLA genotype disparities in type 1 diabetes Tissue Antigens 69 Suppl 1 101 105 17445178 10.1111/j.1399-0039.2006.7625.x (Pubitemid 46625865)
31. AK Moesta T Graef L Abi-Rached AM Older Aguilar LA Guethlein P Parham 2010 Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I J Immunol 185 4233 4237 20802150 10.4049/jimmunol.1001951 1:CAS:528:DC%2BC3cXhtFyisrbK
32. CA Stewart F Laugier-Anfossi F Vély, et al. 2005 Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors Proc Natl Acad Sci USA 102 13224 13229 16141329 10.1073/pnas.0503594102 1:CAS:528:DC%2BD2MXhtVejsr%2FM (Pubitemid 41325005)
33. CC Patterson GG Dahlquist E Gyurus A Green G Soltesz 2009 Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet 373 2027 2033 19481249 10.1016/S0140-6736(09)60568-7
34. M Rodacki B Svoren V Butty, et al. 2007 Altered natural killer cells in type 1 diabetic patients Diabetes 56 177 185 17192480 10.2337/db06-0493 1:CAS:528:DC%2BD2sXhtVWlt7g%3D
35. A Willcox SJ Richardson AJ Bone AK Foulis NG Morgan 2009 Analysis of islet inflammation in human type 1 diabetes Clin Exp Immunol 155 173 181 19128359 10.1111/j.1365-2249.2008.03860.x 1:STN:280:DC%2BD1M%2FlslKltw%3D%3D
36. F Dotta S Censini AG van Halteren, et al. 2007 Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients Proc Natl Acad Sci USA 104 5115 5120 17360338 10.1073/pnas.0700442104 1:CAS:528:DC%2BD2sXjvFChu7o%3D (Pubitemid 47186185)
37. C Gur A Porgador M Elboim, et al. 2010 The activating receptor NKp46 is essential for the development of type 1 diabetes Nat Immunol 11 121 128 20023661 10.1038/ni.1834 1:CAS:528:DC%2BD1MXhsFyhsLnN